- Home
- LGND vs SPNT Comparison
LGND vs SPNT Comparison
Compare LGND & SPNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGND
- SPNT
- Stock Information
- Founded
- LGND 1987
- SPNT 2011
- Country
- LGND United States
- SPNT Bermuda
- Employees
- LGND N/A
- SPNT N/A
- Industry
- LGND Biotechnology: Pharmaceutical Preparations
- SPNT Property-Casualty Insurers
- Sector
- LGND Health Care
- SPNT Finance
- Exchange
- LGND Nasdaq
- SPNT Nasdaq
- Market Cap
- LGND 2.0B
- SPNT 2.2B
- IPO Year
- LGND 1992
- SPNT N/A
- Fundamental
- Price
- LGND $114.07
- SPNT $19.28
- Analyst Decision
- LGND Strong Buy
- SPNT Hold
- Analyst Count
- LGND 8
- SPNT 1
- Target Price
- LGND $144.71
- SPNT $17.00
- AVG Volume (30 Days)
- LGND 116.0K
- SPNT 525.3K
- Earning Date
- LGND 08-05-2025
- SPNT 07-31-2025
- Dividend Yield
- LGND N/A
- SPNT N/A
- EPS Growth
- LGND N/A
- SPNT N/A
- EPS
- LGND N/A
- SPNT 0.96
- Revenue
- LGND $181,488,000.00
- SPNT $2,682,300,000.00
- Revenue This Year
- LGND $18.41
- SPNT $11.96
- Revenue Next Year
- LGND $18.87
- SPNT $6.66
- P/E Ratio
- LGND N/A
- SPNT $20.13
- Revenue Growth
- LGND 53.40
- SPNT N/A
- 52 Week Low
- LGND $77.53
- SPNT $11.96
- 52 Week High
- LGND $129.90
- SPNT $20.00
- Technical
- Relative Strength Index (RSI)
- LGND 62.44
- SPNT 52.99
- Support Level
- LGND $111.88
- SPNT $18.96
- Resistance Level
- LGND $116.16
- SPNT $20.00
- Average True Range (ATR)
- LGND 3.58
- SPNT 0.51
- MACD
- LGND 0.89
- SPNT -0.09
- Stochastic Oscillator
- LGND 85.19
- SPNT 44.62
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
About SPNT SiriusPoint Ltd.
SiriusPoint Ltd provides property and casualty reinsurance coverage to insurance and reinsurance companies in the United States, Canada, Bermuda, the United Kingdom, and Europe. The company operates through two operating segments: Reinsurance and Insurance & Services. The company's product portfolio consists of reinsurance contracts for property insurance including both residential and commercial properties, workers' compensation, personal automobile, businesses' general liability insurance, professional liability insurance to protect professional advisors and service providers, agriculture insurance, and mortgage insurance. The majority of the revenue is generated from its Insurance & Services segment.